Skip to main content
. 2017 Aug 24;61(9):e00310-17. doi: 10.1128/AAC.00310-17

FIG 4.

FIG 4

Hemolysis and cytotoxicity testing for diflunisal. (a) Human erythrocytes were treated with serial dilutions of Triton X-100 (0.00 to 1%) or diflunisal (0.06 to 64 μg/ml). (b) The viability of HepG2 cells was measured after treatment with serially diluted concentrations (1 to 64 μg/ml) of diflunisal. Data represent the means ± standard errors of the means (n = 3).